The Little Princess Trust is represented at SIOP Europe

The Little Princess Trust is delighted to be attending one of the biggest annual events for the childhood research community.

SIOP Europe is taking place this week in Budapest and aims to address two key goals over the next decade: to increase the cure rate and the quality of care for children with cancer.

Phil Brace, Chief Executive of The Little Princess Trust, and Simon Tarplee, one of LPT’s Trustees, are both out in Hungary and are excited to hear how some of the research projects we are funding are developing and creating hope for a brighter future.

The sixth annual meeting of SIOP (International Society of Paediatric Oncology) Europe brings together oncologists, parents and survivor representatives, and working groups.

The meeting format is unique: it includes novel session formats, interactive workshops and forums empowering the attendees to debate and disseminate the outcomes of the high-quality clinical research carried out in Europe.

It’s great to see the European research community networking so effectively.

Mr Brace said that, as one of the UK’s largest funders of childhood cancer research, there are so many benefits for The Little Princess Trust to gain from attending SIOP Europe.

“This is a platform for sharing, educating and in some cases debating,” he added.

“It’s great to see the European research community networking so effectively. It gives us the opportunity to ensure our funding is appropriate and evidenced.”

Among the people we have met at SIOP Europe are Professor Pam Kearns, Chair of Clinical Paediatric Oncology at the University of Birmingham, and Ashley Ball-Gamble, the Chief Executive of CCLG.

CCLG’s administrative expertise and scientific knowledge has been a huge help to The Little Princess Trust’s research funding.

Mr Ball-Gamble said that SIOP Europe was a great opportunity to learn about current research, as well as understanding the future direction of research and where the current gaps are.

“This ensures LPT’s research strategy aligns with the priorities of the research community and can focus on investing in research where it is most needed and will have the most impact,” he added.